Bitget App
Trade smarter
Buy cryptoMarketsTradeFuturesEarnAISquareMore
BridgeBio Oncology Therapeutics, Inc. (Bbot) announced that its innovative therapy Bbo-11818, for adult patients with advanced KRAS-mutated pancreatic ductal adenocarcinoma, has been granted Fast Track designation by the U.S. Food and Drug Administration (FDA).

BridgeBio Oncology Therapeutics, Inc. (Bbot) announced that its innovative therapy Bbo-11818, for adult patients with advanced KRAS-mutated pancreatic ductal adenocarcinoma, has been granted Fast Track designation by the U.S. Food and Drug Administration (FDA).

老虎证券老虎证券2026/04/20 20:18
Show original
This designation will accelerate the development and review process of the candidate drug, bringing new treatment hope to patient groups with urgent unmet medical needs. As the most common type of pancreatic cancer, KRAS-mutant pancreatic ductal adenocarcinoma has long lacked effective targeted therapy options. Obtaining Fast Track designation not only demonstrates the therapeutic potential Bbo-11818 has shown in early research, but also means the drug can benefit from more frequent communication with the FDA during subsequent clinical trials, potentially expediting its progress to the marketing application stage.
0
0

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.
Trade now!

You may also like

Qualcomm (QCOM.US) acquires robotics software company PickNik to strengthen its presence in the physical AI field

Qualcomm announced on Wednesday that it will acquire the robotics software company PickNik to enhance its presence in the field of physical AI and robotics.

智通财经2026/09/24 01:16

Four Mac Studio systems run trillion-parameter models, Apple challenges Nvidia's narrative on inference

Apple's hardware chief pointed out that after enterprises purchase devices outright, there is no need to pay by token, and the cost-effectiveness of local computing power might be superior to long-term rental of cloud GPUs. Goldman Sachs believes that if more inference tasks shift to end devices, Nvidia's share in incremental AI activity may fall short of market expectations. Currently, Nvidia's implied volatility is at its lowest since before the pandemic, and option pricing has almost no risk premium allocated for this narrative change. Therefore, Goldman Sachs recommends buying Nvidia put options and going long on Apple.

华尔街见闻2026/09/24 01:01

Canadian Prime Minister: US-Canada trade agreement is still possible, but Ottawa will not give up its right to deepen cooperation with the EU

Canadian Prime Minister Carney stated that while it remains possible to reach a trade agreement with the United States, Canada will not trade its sovereignty for any deal, particularly insisting on its right to independently sign trade agreements. Meanwhile, Carney is actively promoting deeper cooperation between Canada and the European Union, covering critical minerals, energy, scientific research, and student exchanges, aiming to reduce dependence on the US and defend national sovereignty. He emphasized that in an era when connectivity can be weaponized, diversified cooperation is a necessary choice for safeguarding sovereignty.

华尔街见闻2026/09/24 01:01